Noosa News
Sun Pharma slashes Tasmanian poppy production following slump in global demand for pain relief
The reduced need for surgical pain relief during the pandemic has forced Tasmanian poppy processor Sun Pharma to cut its growing area for the coming season.
Key points:
- Sun Pharma has slashed the size of its growing area across Tasmania as global demand for painkillers falls
- Twenty growers in the state’s south will be cut and a further 150 will have their contracts reduced
- Worldwide demand for opium-based pain relief dropped to an all-time low last year as elective surgeries were cancelled
The multinational, which contracts growers across the state to produce poppies for its factory at Latrobe, has also made two field officers redundant as part of the cuts.
Worldwide demand for opium-based pain relief dropped to an all-time low last…
Continue Reading
-
General19 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General17 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News18 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
Noosa News18 hours agoBack to the Future the Musical’s extraordinary visual effects mean you’ll see the DeLorean fly